M&A
-
Hospital-at-home companies DispatchHealth, Medically Home to merge
DispatchHealth CEO Jennifer Webster will lead the combined company once the deal closes, which is expected in mid-2025.
By Emily Olsen • March 21, 2025 -
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth testing areas.
By Susan Kelly • March 12, 2025 -
FTC challenges $627M private equity takeover of Surmodics
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate significant head-to-head competition.”
By Nick Paul Taylor • March 7, 2025 -
Trump administration policies could create headwinds across healthcare: Fitch
The credit ratings agency is most concerned about Medicaid cuts and how government layoffs will affect device approvals.
By Susanna Vogel • March 5, 2025 -
Boston Scientific to buy Sonivie for up to $540M
Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its Sonivie acquisition.
By Ricky Zipp • March 3, 2025 -
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions
Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.
By Susan Kelly • Feb. 27, 2025 -
Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B
Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.
By Susan Kelly • Feb. 25, 2025 -
Quest to buy Fresenius Medical Care kidney testing assets
The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests and other end-stage kidney disease services for Fresenius Medical Care.
By Nick Paul Taylor • Feb. 25, 2025 -
FTC retains stricter merger guidelines under Trump
FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in place — for now.
By Rebecca Pifer • Feb. 20, 2025 -
Medtronic buys Nanovis’ nano technology for use in spine implants
Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.
By Nick Paul Taylor • Feb. 13, 2025 -
M&A and a separation take center stage in latest earnings season
BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.
By Susan Kelly • Feb. 10, 2025 -
Globus to buy Nevro for $250M
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.
By Elise Reuter • Feb. 6, 2025 -
Zimmer touts ASC opportunity with Paragon 28 purchase
With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.
By Elise Reuter • Feb. 6, 2025 -
2025 outlook
Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty
Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.
By Ricky Zipp • Jan. 31, 2025 -
Zimmer to buy Paragon 28 for $1.1B
Needham analysts, who were surprised by the bargain for Paragon 28, said Zimmer may not be done spending.
By Ricky Zipp • Jan. 29, 2025 -
Stryker to sell spinal implants business
The company named a new CFO and shared an update on its planned Inari Medical acquisition.
By Elise Reuter • Jan. 29, 2025 -
Philips to sell emergency care business
Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.
By Elise Reuter • Jan. 28, 2025 -
Intuitive inks deals to sell robots in Italy, Spain and Portugal
Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, Spain, Portugal, Malta and San Marino.
By Nick Paul Taylor • Jan. 23, 2025 -
Medtronic inks distribution deal with Contego with option to buy firm
Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.
By Ricky Zipp • Jan. 13, 2025 -
Deep Dive // 2025 outlook
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.
By Ricky Zipp • Jan. 9, 2025 -
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
By Susan Kelly • Jan. 8, 2025 -
Retrieved from Stryker Corporation on January 06, 2025
Stryker to buy Inari Medical for nearly $5B
Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari Medical.
By Ricky Zipp • Jan. 6, 2025 -
Top 10 medtech deals of 2024
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
By Nick Paul Taylor • Jan. 2, 2025 -
Labcorp closes takeover of Ballad Health outreach laboratory services
Labcorp continued its streak of hospital lab purchases with a deal that will expand its testing capabilities to communities in Tennessee, Virginia, North Carolina and Kentucky.
By Nick Paul Taylor • Dec. 12, 2024 -
Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor
Last week, Patterson Companies announced it would seek strategic alternatives after the company’s profit decreased by one-third in its fiscal second quarter.
By Elise Reuter • Dec. 11, 2024